Welcure Drugs & Pharmaceuticals Ltd Intrinsic Value
WELCURE · Healthcare · Current price ₹0.23
Is Welcure Drugs & Pharmaceuticals Ltd undervalued?
DocStoX estimates the fair value of Welcure Drugs & Pharmaceuticals Ltd at ₹1 per share, versus the current market price of ₹0. That puts the stock about +334.8% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 1 independent method: Residual income (₹1). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹1 (bear) to ₹1 (base) to ₹1 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹0 versus an intrinsic value of ₹1, Welcure Drugs & Pharmaceuticals Ltd currently offers +334.8% of margin.
More on Welcure Drugs & Pharmaceuticals Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.